News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.
A8 (Ancient8) fluctuated 43.0% in 24 hours: Low liquidity drives price rebound and correction
Bitget Pulse·2026/03/15 22:03
C (Chainbase) fluctuated by 63.1% in 24 hours: surge in trading volume and open interest triggers speculative pump
Bitget Pulse·2026/03/15 22:03
CLARITY Act risks handing crypto to centralized players: Gnosis exec
Cointelegraph·2026/03/15 21:33
Software Dev: XRP Price Will Massively Rise Once USA Makes This Announcement
TimesTabloid·2026/03/15 21:09
MYX (MYXFinance) fluctuates 51.1% in 24 hours: Surge in trading volume and active futures market drive movement
Bitget Pulse·2026/03/15 20:22
aPriori (APR) 24-hour amplitude at 52.2%: Abnormal buying surge drives drastic price fluctuations
Bitget Pulse·2026/03/15 20:20
Flash
12:38
Cannae Holdings, Inc. has successfully completed the full acquisition of Exeter Rugby Group, significantly advancing the company's strategic shift to focus its investments on sports and entertainment assets.By acquiring full ownership of the rugby club, Cannae Holdings further consolidates its presence in the sector, aiming to identify and integrate high-value entertainment assets. This strategic acquisition not only expands the company's asset portfolio but also positions it more advantageously in the rapidly evolving sports entertainment market.
12:38
Moleculin Biotech, Inc. (Moleculin) recently announced the interim analysis results of its phase 2/3 "Miracle" clinical trial, showing positive data.The results show that the core candidate drug Annamycin demonstrated significantly superior efficacy in inducing complete remission compared to the control group, with the complete remission rate reaching three times that of the control group. This positive data provides strong momentum for the further development of Annamycin in the treatment of acute myeloid leukemia. The success of the interim analysis indicates that the drug has made breakthrough progress in key efficacy indicators, and it is expected to offer new treatment options for patients. The company will continue to advance clinical trials to obtain more confirmatory data.
12:37
U.S. Stock Index Futures Turn Lower On June 30, Dow Jones futures fell by 0.11%, S&P 500 futures declined by 0.07%, and Nasdaq 100 futures decreased by 0.05%.
News